HIV care providers from across

HIV clinical trials Atlanta

The National Institutes of Health (NIH) has selected the Emory-CDC HIV/AIDS Clinical Trials Unit as one of 37 clinical trials units (CTUs) responsible for implementing the scientific agenda of the NIH international HIV/AIDS clinical research network. The NIH CTU effort is directed and funded by the National Institute of Allergy and Infectious Diseases (NIAID).

The seven-year designation, with expected core funding of more than $12.5 million and significant additional protocol-specific funding, includes Emory and the Centers for Disease Control and Prevention (CDC), with two clinical research sites in Atlanta and one each in Kenya and Thailand.

The Emory-CDC HIV/AIDS CTU will conduct clinical trials within three networks sponsored by the NIH:

  • the AIDS Clinical trials Group (ACTG),
  • HIV Vaccine Trials Network (HVTN) and
  • HIV Prevention Trials Network (HPTN).

Emory's HIV/AIDS Clinical Trials Unit (CTU) first received NIH designation in 2007, but the new designation and the inclusion of CDC and international sites will significantly boost its clinical trials work in HIV/AIDS.

The new awards are intended to expand the scope of the network's current activities to include the treatment and prevention of other infectious diseases, including tuberculosis and hepatitis, which are the most significant co-infections for people infected with, or at risk for, HIV.

Principal Investigators

The three CTU principal investigators are:

  • Jeffrey Lennox, MD, associate dean for clinical research and professor of medicine at Emory University School of Medicine;
  • Carlos del Rio, MD, Hubert Professor and Chair of the Hubert Department of Global Health at Emory's Rollins School of Public Health and professor of medicine at Emory University School of Medicine; and
  • Mark J. Mulligan, MD, professor of medicine at Emory School of Medicine and executive director of the Hope Clinic of the Emory Vaccine Center.
LAP LAMBERT Academic Publishing The Patients Voice in HIV/AIDS Clinical Trial Participation: What motivates the willingness of HIV infected people to take part in HIV/AIDS clinical trials?
Book (LAP LAMBERT Academic Publishing)
  • Used Book in Good Condition

BMC Medical Research Methodology at the 35th Annual Conference of the ..  — BMC Pediatrics
The conference will focus on issues such as design and analysis of clinical trials, methods in biostatistics and development of clinical prediction models.

Popular Q&A

It relation to HIV clinical trials, what does ACTG stand for?

The AIDS Clinical Trials Group (ACTG) is the largest HIV clinical trials organisation in the world, playing a major role in setting standards of care.

Related Posts